These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38648923)

  • 21. Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women.
    Darlington M; Carbonne B; Mailloux A; Brossard Y; Levy-Mozziconacci A; Cortey A; Maoulida H; Simon T; Rousseau A; Durand-Zaleski I;
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):496. PubMed ID: 30547830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy.
    Aitken SL; Tichy EM
    Am J Health Syst Pharm; 2015 Feb; 72(4):267-76. PubMed ID: 25631833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of Rh isoimmunization: should threatened first-trimester abortion be an indication for Rh immune globulin prophylaxis?
    Dayton VD; Anderson DS; Crosson JT; Cruikshank SH
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 1):63-4. PubMed ID: 2115737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective quantification of fetomaternal hemorrhage with dilation and evacuation procedures.
    Hsia JK; Schimmoeller NR; Cansino CD; Hou MY; Jensen HM; Creinin MD
    Contraception; 2019 May; 99(5):281-284. PubMed ID: 30500335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Policies and procedures related to weak D phenotype testing and Rh immune globulin administration. Results from supplementary questions to the Comprehensive Transfusion Medicine Survey of the College of American Pathologists.
    Domen RE
    Arch Pathol Lab Med; 2000 Aug; 124(8):1118-21. PubMed ID: 10923069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Underutilization of Rh prophylaxis in the emergency department: a retrospective survey.
    Grant J; Hyslop M
    Ann Emerg Med; 1992 Feb; 21(2):181-3. PubMed ID: 1310836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of Rhesus-D Alloimmunization in the First Trimester of Pregnancy: Economic Analysis of Three Management Strategies.
    Dochez V; Chabernaud C; Schirr-Bonnans S; Riche VP; Thubert T; Winer N; Vigoureux S
    Transfus Med Rev; 2024 Jan; 38(1):150778. PubMed ID: 37925226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guideline No. 448: Prevention of Rh D Alloimmunization.
    Fung-Kee-Fung K; Wong K; Walsh J; Hamel C; Clarke G
    J Obstet Gynaecol Can; 2024 Apr; 46(4):102449. PubMed ID: 38553007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures.
    Bowman JM; Pollock JM
    Transfus Med Rev; 1987 Aug; 1(2):101-12. PubMed ID: 2856541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACOG practice bulletin. Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin Number 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology.
    Int J Gynaecol Obstet; 1999 Jul; 66(1):63-70. PubMed ID: 10458556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant.
    Jones ML; Wray J; Wight J; Chilcott J; Forman K; Tappenden P; Beverley C
    BJOG; 2004 Sep; 111(9):892-902. PubMed ID: 15327601
    [No Abstract]   [Full Text] [Related]  

  • 33. Consensus conference on anti-D prophylaxis, April 7 & 8, 1997: final consensus statement. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists.
    Urbaniak SJ
    Transfusion; 1998 Jan; 38(1):97-9. PubMed ID: 9482402
    [No Abstract]   [Full Text] [Related]  

  • 34. Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis.
    Moise KJ
    Obstet Gynecol; 2013 Dec; 122(6):1306. PubMed ID: 24264705
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell free fetal DNA to triage antenatal rhesus immune globulin: Is it really cost-effective in the United States?
    Moise KJ; Hashmi SS; Markham K; Argoti PS; Bebbington M
    Prenat Diagn; 2019 Feb; 39(3):238-247. PubMed ID: 30610742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compliance with postpartum Rh isoimmunization prophylaxis in Alberta.
    Huchcroft S; Gunton P; Bowen T
    CMAJ; 1985 Nov; 133(9):871-5. PubMed ID: 2996738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rh-immunoglobulin: Rh prophylaxis.
    Bowman J
    Best Pract Res Clin Haematol; 2006; 19(1):27-34. PubMed ID: 16377539
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of Rh Immune Globulin in First-Trimester Abortion and Miscarriage.
    Gilmore E; Sonalkar S; Schreiber CA
    Obstet Gynecol; 2023 Jan; 141(1):219-222. PubMed ID: 36701622
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of Rh Immune Globulin in First-Trimester Abortion and Miscarriage.
    Moise KJ
    Obstet Gynecol; 2023 Apr; 141(4):862. PubMed ID: 36961969
    [No Abstract]   [Full Text] [Related]  

  • 40. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists.
    Lee D; Contreras M; Robson SC; Rodeck CH; Whittle MJ
    Transfus Med; 1999 Mar; 9(1):93-7. PubMed ID: 10216910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.